In patients with late‐onset AD, NEP mRNA and protein levels are selectively reduced in brain regions extremely vulnerable to AD pathology,31 and NEP levels and activity decrease in human and rodent brains with aging, suggesting that reduction in NEP levels may contribute to the development of late‐onset AD.32 This evidence concerns the gene MME and Alzheimer disease.